Inhibition of matrix metalloproteases by substituted biaryl oxob

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544183, 544237, 544298, 544285, 544287, 540504, 548531, 548210, 548221, 548183, 5483175, 5483615, 5483044, 546142, 562495, A61K 3153, C07D25310, C07C 6364

Patent

active

059256370

ABSTRACT:
Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented. The compounds of the invention have the generalized formulas: ##STR1## wherein r is 0-2, T is selected from ##STR2## and R.sup.40 is a mono- or bi-heterocyclic structure. These compounds are useful for inhibiting matrix metalloproteases and, therefore, combating conditions to which MMP's contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, comeal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibularjoint disease, demyelating diseases of the nervous system, tumor metastasis or degenerative cartilage loss following traumatic joint injury, and coronary thrombosis from athrosclerotic plaque rupture. The present invention also provides pharmaceutical compositions and methods for treating such conditions.

REFERENCES:
Sahoo, et al., Inhibition of Matrix Metalloproteinases by N-Carboxyalkyl Dipeptides: Enhanced Potency and Selectivity with Substituted P.sub.1 ' Homophenylanines, Biorganic & Medicinal Chemistry Letters, 5(20), 2441-2446 (1995).
Child, et al., Fenbufen, a New Anti-Inflammatory Analgesic: Synthesis and Structure-Activity Relationships of Analogs, Journal of Pharmaceutical Sciences, 66(4), 466-476 (1977).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of matrix metalloproteases by substituted biaryl oxob does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of matrix metalloproteases by substituted biaryl oxob, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of matrix metalloproteases by substituted biaryl oxob will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1322030

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.